DCT startup looking to forge better community relationships nets a modest Series B

The decentralized clinical trial industry went through a huge boom during the Covid-19 pandemic as biotechs and Big Pharma companies alike were forced to shift gears. Looking to capitalize on that momentum, a San Francisco startup is raising funds to ensure closer partnerships with the communities DCTs serve.

Curebase pulled...

Click to view original post